Noninvasive plaque imaging to accelerate coronary artery disease drug development

GA Figtree, PD Adamson, C Antoniades… - Circulation, 2022 - Am Heart Assoc
Coronary artery disease (CAD) remains the leading cause of adult mortality globally.
Targeting known modifiable risk factors has had substantial benefit, but there remains a …

Positron emission tomography in the diagnosis and follow-up of transthyretin amyloid cardiomyopathy patients: a systematic review

HSA Tingen, A Tubben, JH Van'T Oever… - European journal of …, 2023 - Springer
Purpose Transthyretin (ATTR) amyloidosis is a progressive protein misfolding disease with
frequent cardiac involvement. This review aims to determine the value of PET in diagnosis …

Coronary artery calcification: current concepts and clinical implications

C Onnis, R Virmani, K Kawai, V Nardi, A Lerman… - Circulation, 2024 - Am Heart Assoc
Coronary artery calcification (CAC) accompanies the development of advanced
atherosclerosis. Its role in atherosclerosis holds great interest because the presence and …

Latent coronary plaque morphology from computed tomography angiography, molecular disease activity on positron emission tomography, and clinical outcomes

J Kwiecinski, M Kolossváry, E Tzolos… - … , and vascular biology, 2023 - Am Heart Assoc
Background: Assessments of coronary disease activity with 18F-sodium fluoride positron
emission tomography and radiomics-based precision coronary plaque phenotyping derived …

Noninvasive in vivo coronary artery thrombus imaging

E Tzolos, R Bing, J Andrews, MG MacAskill… - Cardiovascular …, 2023 - jacc.org
Background The diagnosis and management of myocardial infarction are increasingly
complex, and establishing the presence of intracoronary thrombosis has major implications …

Recent advances in cardiovascular diseases research using animal models and PET radioisotope tracers

W Wargocka-Matuszewska, W Uhrynowski… - International Journal of …, 2022 - mdpi.com
Cardiovascular diseases (CVD) is a collective term describing a range of conditions that
affect the heart and blood vessels. Due to the varied nature of the disorders, distinguishing …

Radiotracers to address unmet clinical needs in cardiovascular imaging, part 2: inflammation, fibrosis, thrombosis, calcification, and amyloidosis imaging

JC Stendahl, JM Kwan, D Pucar… - Journal of Nuclear …, 2022 - Soc Nuclear Med
Cardiovascular imaging is evolving in response to systemwide trends toward molecular
characterization and personalized therapies. The development of new radiotracers for PET …

Vessel-by-vessel analysis of lower extremity 18F-NaF PET/CT imaging quantifies diabetes- and chronic kidney disease-induced active microcalcification in patients …

TH Chou, ET Rimmerman, S Patel, MK Wynveen… - EJNMMI research, 2023 - Springer
Background Positron emission tomography (PET)/computed tomography (CT) imaging with
fluorine-18 (18F)-sodium fluoride (NaF) provides assessment of active vascular …

HAP-multitag, a PET and positive MRI contrast nanotracer for the longitudinal characterization of vascular calcifications in atherosclerosis

J Pellico, I Fernández-Barahona… - … Applied Materials & …, 2021 - ACS Publications
Vascular microcalcifications are associated with atherosclerosis plaque instability and,
therefore, to increased mortality. Because of this key role, several imaging probes have …

In Vivo Coronary 18F-Sodium Fluoride Activity: Correlations With Coronary Plaque Histological Vulnerability and Physiological Environment

W Wen, M Gao, M Yun, J Meng, W Yu, Z Zhu… - Cardiovascular …, 2023 - jacc.org
Abstract Background 18F-sodium fluoride (18F-NaF) positron emission tomography
(PET)/computed tomography (CT) is a promising new approach for assessing …